Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive data.
This move was revealed following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative has since explained that the United States was seeking biological samples for research and profit while was unwilling to guarantee the benefits from future vaccines.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for more dialogue to reach a agreement acceptable to both sides so the nation's critical HIV programme can continue.
Wider Implications
This development comes after a similar case in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were filed about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance openness and accountability.
According to statements, Sixteen African countries have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to provide its biological resources and data indefinitely, without any corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens should a new pandemic emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already set up through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is intended to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how subsequent collaboration could be structured in a manner that honours the independence and interests of each country."
Health Experts Response
A leading public health body said it understood the official position, but suggested that talks must proceed considering much of the nation's HIV programmes depended on international support.
"If technical issues exist, such as those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The situation highlights the complex challenges between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.